Conmed (CNMD) Tops Q2 View By 2c; Reducing Guidance
CNMD Hot Sheet
Revenue Growth %: +5.9%Financial Fact:
Cost of sales: 93.41M
Today's EPS Names:
TARO, BRLI, TLB, More
Conmed (Nasdaq: CNMD) reports Q2 EPS of $0.17, 2 cents better than the analyst estimate of $0.15. Revenue for the quarter was $164.6 million, versus the consensus of $163.04 million.
Reducing sales guidance by $10.0 million to $670 - $680 million versus $671.34M and the non-GAAP EPS guidance by $0.07 to $0.85 - $0.95 versus consensus of $0.94.
Sign up at EasyStockAlerts for free to see your stock news before it breaks to the rest of the public!
Reducing sales guidance by $10.0 million to $670 - $680 million versus $671.34M and the non-GAAP EPS guidance by $0.07 to $0.85 - $0.95 versus consensus of $0.94.
Sign up at EasyStockAlerts for free to see your stock news before it breaks to the rest of the public!
You May Also Be Interested In
- UPDATE: Bristow Group (BRS) Reports Better-Than-Expected Q4 Results; Offers FY13 Outlook
- Hewlett-Packard Company (HPQ) Tops Q2 EPS by 7c; Guides Q3 Below the Street, Raises FY12 Outlook
- Semtech Corp (SMTC) Misses Q1 EPS by 4c; Guides Q2
Create E-mail Alert Related Categories
Earnings, GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
